Navigation Links
Lo studio pubblicato su European Radiology esalta ulteriormente l'utilizzo della tomosintesi al seno di Hologic nell'ambito dello screening del cancro con utilizzo della doppia lettura
Date:4/22/2013

risultati del presente studio  rafforzino  ulteriormente l'adozione della nostra tecnologia di tomosintesi".

L'articolo di European Radiology rappresenta la prima pubblicazione a revisione paritaria che confronta i risultati degli esami 2D a doppia lettura con la doppia lettura del 2D abbinata all'imaging di tomosintesi in un grande trial clinico prospettico.

La tecnologia di tomosintesi al seno di Hologic è approvata dal 2008 nei Paesi che riconoscono il marchio CE. Negli Stati Uniti è stata approvata a Febbraio del 2011 per l'utilizzo nello screening e nella clinica per la diagnosi del cancro al seno. I sistemi Hologic sono attualmente in uso in 48 Stati negli Stati Uniti e in oltre 50 Paesi.

Per maggiori informazioni sulla tecnologia di tomosintesi al seno di Hologic, visitare il sito Web http://www.breasttomo.com/ (per operatori sanitari) e http://www.hologic3d.com/ (per pazienti).

Informazioni su Hologic, Inc.Hologic, Inc. è leader nello sviluppo, nella produzione e nella fornitura di prodotti diagnostici, sistemi medici di acquisizione delle immagini e di prodotti chirurgici di alta qualità. La Società gestisce quattro unità aziendali chiave concentrate sulla diagnostica, sulla salute del seno e sulla salute scheletrica e chirurgica in ambito ginecologico. Con una gamma completa di tecnologie e un efficace programma di ricerca e sviluppo, Hologic è impegnata nel miglioramento della vita. La Società ha sede nel Massachusetts (USA).

Hologic è un marchio e/o marchio registrato di Hologic, Inc., e/o delle sue consociate negli Stati Uniti e/o in altri Paesi.

Dichiarazione previsionale di non responsabilità.Questo comunicato stampa potrebbe contenere informazioni previsionali che implicano rischi e incertezze, incluse le dichiarazioni circa l'utiliz
'/>"/>

SOURCE Hologic, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Daiichi Sankyo ha completato larruolamento dei pazienti per lo studio Hokusai-VTE su Edoxaban, il più ampio trial clinico di fase 3 per il trattamento delle tromboembolie venose ricorrenti
2. Anthony Creed Joins DDSTUDIO As GM, Experience Design
3. Study Published in European Radiology Further Supports the Use of Hologics Breast Tomosynthesis in Cancer Screening in Practices Using Double Reads
4. Moravia Provides Guidance to Life Sciences Sector as Croatia Nears EU Accession and European Medicines Agency Deadlines Loom
5. Fifteen Pioneering Inventors Nominated for European Inventor Award
6. European Dental Biomaterial Revenues Will Grow To Over $375 Million In 2021, In Line With Rising Dental Implant Placements
7. Western European Endoscopic Devices Market to Benefit from Increase in Minimally Invasive Surgeries, Says Frost & Sullivan
8. European Nuclear Medicine / Radiopharmaceuticals Market Worth by Reach $1.6 Billion by 2017
9. SonaCare Medical Successfully Launches New Products at European Association of Urology (EAU)
10. N30 Pharma Announces Presentation of Preclinical Data at the Basic Science Meeting of the European Cystic Fibrosis Society
11. Chimerixs Antiviral CMX001 Abstract Selected for an Oral Presentation at the European Group for Blood and Marrow Transplantations Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... ROCHESTER, N.Y. , July 23, 2014 ... VSCP ), a leading provider of clinical trial ... , 48, has been named president and chief executive ... of Directors in August 2013 and has held the ... October 25, 2013. Dr. Charles E. ...
(Date:7/23/2014)... 23, 2014 Research and Markets ... in Consumer Healthcare by Application, Sensor Type & by ... 2020" report to their offering. ... an increasing momentum for consumer healthcare monitoring and sensing ... consumer healthcare will lessen the healthcare cost of the ...
(Date:7/23/2014)... MOUNTAIN VIEW, Calif. , July 23, ... in translational preclinical research, today unveiled their new logo ... the transformation of Surpass, corporate culture to one where ... customers. This press release comes on the heels of ... added to the Silicon Valley Team:  David Craig, a ...
Breaking Medicine Technology:Eric T. Converse Named President And Chief Executive Officer Of VirtualScopics, Inc. 2Eric T. Converse Named President And Chief Executive Officer Of VirtualScopics, Inc. 3Eric T. Converse Named President And Chief Executive Officer Of VirtualScopics, Inc. 4Sensor Market in Consumer Healthcare (Patient Monitoring, Therapeutic, Handheld and Homecare, & Fitness and wellness) - Analysis & Forecast to to 2013 - 2020 2Sensor Market in Consumer Healthcare (Patient Monitoring, Therapeutic, Handheld and Homecare, & Fitness and wellness) - Analysis & Forecast to to 2013 - 2020 3SURPASS Launches New Company Logo and Corporate Website, Symbolizing Transformation of Company Culture to Meet the Changing Needs of Clients in the Life Science Community Today. 2SURPASS Launches New Company Logo and Corporate Website, Symbolizing Transformation of Company Culture to Meet the Changing Needs of Clients in the Life Science Community Today. 3
... Sept. 30, 2011 Haemonetics Corporation (NYSE: ... quarter of its 2012 fiscal year on October 31, ... hold a webcast to discuss and answer questions about ... 31, 2011. Webcast Link: http://phx.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&c=72118&eventID=4204617 ...
... Sept. 29, 2011 Boston Scientific Corporation (NYSE: ... ( NE ural C ardiac T her A ... a prospective, randomized, international clinical feasibility study designed to assess ... heart failure patients.  The study will evaluate 96 patients with ...
Cached Medicine Technology:Boston Scientific Begins Enrollment in NECTAR-HF Clinical Trial 2Boston Scientific Begins Enrollment in NECTAR-HF Clinical Trial 3Boston Scientific Begins Enrollment in NECTAR-HF Clinical Trial 4
(Date:7/23/2014)... Vancouver, BC (PRWEB) July 23, 2014 ... has recently announced the launch of its custom orthotics ... correcting and eliminating foot abnormalities in order to restore ... the joints and cause less fatigue and pain. In ... and reduced pressure in the foot, resulting in relief ...
(Date:7/23/2014)... latest blog post, Best Drug Rehabilitation , which offers ... a stay in rehab can make a big difference in ... a topic that is quickly becoming among the most important ... The Best Drug Rehabilitation blog post on opiate abuse facts ... why they’re considered “the mother of all Schedule II drugs” ...
(Date:7/23/2014)... Children and teens who lose a parent might face an ... study suggests. People who were children or teens when ... death during the study period than those who had not ... Although the study found an association between a parent,s ... wasn,t designed to prove cause-and-effect. Also, the increased risk ...
(Date:7/23/2014)... (PRWEB) July 23, 2014 The European ... in Europe with analysis and projection of revenue. The ... $812.03 million in 2012 to $1,202.08 million by 2018, ... , Browse through the TOC of the European Vitamins ... analysis provided. This also provides a glimpse of the ...
(Date:7/23/2014)... a distinguished electrical equipment retailer, has recently unveiled its collection ... company has decided to provide big price cuts for all ... for the company’s brand new SMA JACK can get a ... quality SMA JACK from RFcnn.com Provides a great help . ... to help make things much easier for worldwide distributors. It ...
Breaking Medicine News(10 mins):Health News:Custom Orthotics at Burnaby PhysioCare Now Correct Foot Abnormalities 2Health News:Latest Best Drug Rehabilitation Blog Post Focuses on Opiate Abuse Facts 2Health News:Parent's Death May Raise Risk of Early Death for Grown Children, Study Suggests 2Health News:Europe Vitamins (Nutraceuticals) Market is Expected to Reach $1,202.08 Million in 2018 - New Report by MicroMarket Monitor 2Health News:Europe Vitamins (Nutraceuticals) Market is Expected to Reach $1,202.08 Million in 2018 - New Report by MicroMarket Monitor 3Health News:Europe Vitamins (Nutraceuticals) Market is Expected to Reach $1,202.08 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Europe Vitamins (Nutraceuticals) Market is Expected to Reach $1,202.08 Million in 2018 - New Report by MicroMarket Monitor 5Health News:New Collection of SMA JACK Released by China Electrical Accessory Manufacturer RFcnn 2
... has developed new guidelines for starting and monitoring treatments ... first JIA guidelines endorsed by the ACR, with the ... Created as a guide for health care providers, ... of multiple medications used in the treatment of JIA, ...
... venues and a lack of motivation even if those ... for adolescent boys, according to recently published research from a ... boys, attitudes led by Lorraine Robbins from MSU,s College of ... the decrease in exercise typically seen in this age group. ...
... , WEDNESDAY, March 30 (HealthDay News) -- Longer periods ... larger brain growth in offspring, which explains why human ... say researchers. They also said the findings from ... offer further proof that breast-feeding is good for brain ...
... at diagnosis for chronic myeloid leukemia (CML) is over 60 ... data are available about the long-term outcome for older patients ... CML. Results from a study published today in ... of Hematology , reveal that age does not affect response ...
... reduced the blood pressure of a 76-year-old woman ... total knee replacement surgery for osteoarthritis (OA). While ... the woman,s blood pressure dropped dramatically when she ... the April issue of Arthritis Care & ...
... HealthDay Reporter , TUESDAY, March 29 (HealthDay News) -- While ... New research suggests that some people with the disease apparently ... kidney and heart disease. In a group of ... years, nearly 43 percent remained free of serious eye disease, ...
Cached Medicine News:Health News:New clinical practice guidelines developed for juvenile idiopathic arthritis 2Health News:New clinical practice guidelines developed for juvenile idiopathic arthritis 3Health News:Lack of motivation, equipment main barriers for exercise for boys 2Health News:Longer Breast-Feeding May Be Key to Bigger Brains 2Health News:Study reveals no impact of age on outcome in chronic myeloid leukemia patients treated with imatinib 2Health News:Case study reports singing lowers patient's blood pressure prior to surgery 2Health News: Some Type 1 Diabetics Seem Shielded Against Complications 2Health News: Some Type 1 Diabetics Seem Shielded Against Complications 3Health News: Some Type 1 Diabetics Seem Shielded Against Complications 4
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: